84eb428b 05c9 4585 83ba 85e800b5b424 01
Lithium Carbonate Tablet, Film Coated, Extended Release
Product Images NDC 23155-763
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lithium Carbonate (NDC 23155-763). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
84eb428b 05c9 4585 83ba 85e800b5b424 02
Label for Lithium Carbonate Extended-Release Tablets, USP 300 mg, film-coated extended-release tablets in a package of 100 tablets. The label shows the product strength, dosage form, and that it is for oral use. The labeler is Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. Additional details include the product identification number and standard pharmaceutical labeling information.*
84eb428b 05c9 4585 83ba 85e800b5b424 03
Label for Lithium Carbonate Extended-Release Tablets, USP 300 mg by Avet Pharma, containing 500 film-coated, extended-release tablets. The label includes storage instructions, dosage form, strength, prescription status (Rx only), and manufacturer information. The NDC is 23155-763.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
